DELOGU, GIOVANNA LUCIA
 Distribuzione geografica
Continente #
EU - Europa 129.733
NA - Nord America 6.160
AS - Asia 1.001
SA - Sud America 15
AF - Africa 12
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 136.932
Nazione #
IT - Italia 128.145
US - Stati Uniti d'America 6.134
CN - Cina 601
UA - Ucraina 509
SE - Svezia 443
SG - Singapore 231
FI - Finlandia 161
DE - Germania 156
GB - Regno Unito 142
FR - Francia 46
IN - India 42
VN - Vietnam 38
BE - Belgio 25
CA - Canada 21
RU - Federazione Russa 19
NL - Olanda 17
KR - Corea 15
JP - Giappone 14
AT - Austria 12
TR - Turchia 12
ES - Italia 11
MY - Malesia 11
IR - Iran 10
PK - Pakistan 10
PL - Polonia 9
RO - Romania 8
DZ - Algeria 7
IE - Irlanda 7
AU - Australia 6
CL - Cile 6
CO - Colombia 5
CZ - Repubblica Ceca 5
EU - Europa 4
HK - Hong Kong 4
BR - Brasile 3
ID - Indonesia 3
PH - Filippine 3
CH - Svizzera 2
EE - Estonia 2
GR - Grecia 2
IQ - Iraq 2
MU - Mauritius 2
MX - Messico 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
ZA - Sudafrica 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 136.932
Città #
Cagliari 123.921
Uta 3.808
Fairfield 660
Chandler 652
Woodbridge 652
Houston 473
Boardman 452
Ashburn 369
Nyköping 324
Wilmington 308
Ann Arbor 300
Jacksonville 297
Seattle 241
Cambridge 219
Dearborn 199
Singapore 125
Nanjing 108
Santa Clara 98
Beijing 88
Helsinki 77
Boston 74
New York 64
Shanghai 58
Los Angeles 46
San Diego 42
Sassari 41
Dong Ket 34
Hebei 33
Guangzhou 32
Milan 31
Redwood City 31
Nanchang 27
Shenyang 27
Brussels 22
Norwalk 21
London 19
Verona 19
Changsha 18
Hefei 18
Mountain View 17
Pune 17
Jinan 16
Rome 16
Kunming 14
Redmond 14
Tianjin 14
Jiaxing 13
Orange 12
Phoenix 12
Toronto 12
Auburn Hills 11
Falls Church 10
Alghero 9
Atlanta 9
Ningbo 9
Padova 9
Washington 9
Enterprise 8
Amsterdam 7
Borås 7
Dublin 7
Nürnberg 7
Saint Petersburg 7
Vienna 7
Wuhan 7
Chengdu 6
Zhengzhou 6
Augusta 5
Brno 5
Chicago 5
Kraków 5
Quartu Sant'Elena 5
Seoul 5
Taizhou 5
Bultei 4
Chiswick 4
Hangzhou 4
Montreal 4
Oristano 4
Serramanna 4
Settimo San Pietro 4
Siracusa 4
Tokyo 4
Walnut 4
A Coruña 3
Bologna 3
Centro 3
Detroit 3
El Bosque 3
Gunzenhausen 3
Gurgaon 3
Hanoi 3
Hisar 3
Islington 3
Kilburn 3
Moscow 3
Oklahoma City 3
Ottawa 3
Philadelphia 3
Putignano 3
Totale 134.443
Nome #
Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease 3.619
2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling 3.609
Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives 3.147
Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives 3.029
Unexpected one-step synthesis of 3-benzoyl-2-phenylbenzofurans under Wittig conditions 2.974
null 2.888
null 2.875
Synthesis and biological activity of 2-phenylbenzofuran derivatives as butyrylcholinerase inhibitors 2.775
Unexpected Synthesis of 2-Phenylbenzofurans under Wittig Conditions 2.705
Synthesis of 2-Phenyl-3-benzoylbenzofurans under Wittig Conditions 2.600
MAO Inhibitory Activity of Bromo-2-phenylbenzofurans: Synthesis, in vitro Study and Docking Calculations 2.513
Progress in the development of small molecules as new human A3 adenosine receptor ligands based on the 3-thiophenylcoumarin core 2.287
Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans 2.186
Unexpected migration of benzoyl group in the synthesis of 3-benzoyl-2-phenylbenzofurans under Wittig conditions 2.095
null 2.084
Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives 2.074
null 2.012
Synthesis and NMR Studies of Novel 2-Eteroarylbenzofuran Derivatives 1.972
null 1.971
Unexpected detection of 3-aroylbenzofuran side products in the synthesis of 2-arylbenzofurans: identification, characterization and comparison with chalcone’s fragmentation patterns using EI/MSn 1.921
Targeting α-(1,4)-glucosidase in Diabetes mellitus Type 2: The Role of New Synthetic Coumarins as Potent Inhibitors 1.898
New halogenated phenylcoumarins as tyrosinase inhibitors 1.884
Synthesis of Nitro-Substituted 2-Phenylbenzofurans Derivatives as Potential Human Monoamine Oxidase Inhibitors 1.747
Evaluation of trypanocidal and antioxidant activities of a selected series of 3-amidocoumarins 1.738
Coumarins as promising scaffold for the treatment of age-related diseases - an overview of the last five years 1.708
null 1.707
Herbal natural products as a source of monoamine oxidase inhibitors: A review 1.703
null 1.698
Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels 1.557
Unexpected migration of a benzoyl group in the intramolecular Wittig reaction of o-acyloxybenzylidenephosphoranes with benzoyl chlorides: One-pot synthesis of isomeric 3-benzoyl-2-phenylbenzofurans 1.518
Structure-based optimization of coumarin hA3 adenosine receptor antagonists 1.495
null 1.487
MAO Inhibitory Activity of 2-Arylbenzofurans versus 3-Arylcoumarins: Synthesis, invitro Study, and Docking Calculations 1.436
null 1.425
A new biological prospective for the 2-phenylbenzofurans as inhibitors of α-glucosidase and of the islet amyloid polypeptide formation 1.370
null 1.299
The preparation of non ionic surfactant vesicles formed from hexacyclophosphazenic derivatives 1.202
null 1.199
Tyrosinase Inhibitor Activity of Coumarin-Resveratrol Hybrids 1.107
Synthesis and in vitro study of nitro- and methoxy-2-phenylbenzofurans as human monoamine oxidase inhibitors 1.099
null 990
Synthesis and Biological Evaluation of 2-Arylbenzofurans as MAO Inhibitors 974
null 947
MAO Inhibitory Activity of 2-Arylbenzofurans versus 3-Arylcoumarins: Synthesis, invitro Study, and Docking Calculations 936
null 915
Euphorbia characias: Phytochemistry and Biological Activities 889
GC-MSn analysis of the crude reaction mixtures from Friedel Craft acylation: unambiguous identification and differentiation of 3-aroylbenzofurans from their 4- and 6-regioisomers 865
null 835
SYNTHESIS AND ANTIOXIDANT ANALYSIS OF NEW 4-HYDROXYCOUMARIN DERIVATIVES 835
Electron and electrospray ionization mass spectrometry in the characterization of some 1-allyl-3-phenylaziridines 832
null 811
null 791
Regioselective synthesis of bromo-substituted 3-arylcoumarins 767
Biopolymer: a sustainable material for food and medical applications 764
ANTITRYPANOSOMAL AND ANTIOXIDANT PROPERTIES OF 4-HYDROXYCOUMARIN DERIVATIVES 757
Structural insight of new butyrylcholinesterase inhibitors based on benzylbenzofuran scaffold 740
null 693
Synthesis of carbocyclic pyrimidine nucleosides using the Mitsunobu reaction: O2- vs. N1-alkylation 686
Monoamine Oxidase (MAO) Inhibitory Activity: 3-Phenylcoumarins versus 4-Hydroxy-3-phenylcoumarins 669
Synthesis and vasorelaxant and platelet antiaggregatory activities of a new series of 6-Halo-3-phenylcoumarins 655
null 625
null 610
Identification of new benzofuran derivatives as STING agonists with broad-spectrum antiviral activity 606
null 599
Hydroxycoumarins as selective MAO-B inhibitors 597
Electron ionization-induced fragmentation of some new dibenzo (d,f)(1,3) dioxepine derivatives 582
SINTESI E CARATTERIZZAZIONE DI PIRIDAZINO FUROCUMARINE 577
ELECTRON IMPACT MASS SPECTROMETRY OF SOME NEUROLEPTIC AMINOALKYL THIOPHENE CYCLOALKANONES 575
null 574
null 566
null 564
REGIOSELECTIVE SYNTHESIS OF HALOGENATED 3-PHENYLCOUMARINS 539
null 531
null 523
Sintesi e Caratterizzazione Strutturale di Derivati Cumarinici Contenenti Gruppi 1,3-Diossolici 512
SYNTHESIS OF 2-PHENYLBENZOFURANS. STRUCTURES WITH RIGID TRANS-RESVERATROL’S CORE 508
null 501
Soluble Polymer-Supported Synthesis of 4-Methyl Coumarin on Modified Poly(ethylene glycol)s 500
MASS SPECTROMETRIC INVESTIGATION OF SOME NEW COUMARIN DERIVATIVES 485
Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin 485
null 478
null 475
null 470
SYNTHESIS OF A NEW CLASS OF PHARMACEUTICALLY RELEVANT NAPHTYRIDINES 464
Phenylbenzofurans: Inhibitors and/or Activators for Mushroom Tyrosinase? 460
Mao inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins 450
Vesicle formation from hexasubstituted cyclophosphazenic derivatives 446
Phenylbenzofurans:inhibitors and/or activators for mushroom tyrosinase? 445
null 443
SYNTHESIS OF SUBSTITUTED 3-ARYL-4-HYDROXYCOUMARINS OF EXPECTED ANTIMICROBIAL ACTIVITY IN TENACIBACULOSIS DISEASE 422
Synthesis of a series of 2-phenylbenzofurans. Structure with rigid trans-resveratrol’s core and their tyrosinase activity. 421
null 415
null 407
null 399
null 393
null 385
Sintesi e caratterizzazione di una nuova classe di derivati cumarinici con 1,3,5-triazina 381
SYNTHESIS AND BIOLOGICAL EVALUATION OF 2-ARYLBEI\ZOFURANS AS MAO INHIBITORS 380
Indium(III) chloride catalyzed one step synthesis of some new dibenzo(d,f)(1,3)dioxepines and 12H-dibenzo(d,g)(1,3)dioxocin derivatives 380
null 374
Totale 117.511
Categoria #
all - tutte 173.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011.064 0 0 0 0 0 4.859 2.951 695 532 569 539 919
2020/202133.618 1.210 1.306 1.598 8.117 6.405 4.184 3.066 2.271 975 1.846 1.570 1.070
2021/20226.485 578 628 269 263 468 554 353 194 934 486 893 865
2022/202312.865 1.008 1.455 1.211 1.207 1.015 1.382 842 1.184 836 807 1.284 634
2023/202414.548 550 535 645 859 1.524 2.472 2.617 903 642 906 1.464 1.431
2024/202522.799 5.226 7.297 3.673 3.556 1.971 1.076 0 0 0 0 0 0
Totale 137.497